XX-650-23 is a small molecule CREB inhibitor that blocks the critical interaction between CREB and its required coactivator, CBP (CREB-binding protein), inducing apoptosis and cell cycle arrest in AML cells, and can be used in the study of acute myelogenous leukaemia (AML).
Molekulargewicht:
288.3
Reinheit:
0.9701
CAS Nummer:
[117739-40-9]
Formel:
C18H12N2O2
Target-Kategorie:
Apoptosis|||Epigenetic Reader Domain
T24212
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten